Functional studies have demonstrated that silencing METTL3 markedly reduces cell proliferation, migration, and invasion of OSCC cells in vitro and reduces tumor volume, tumor weight, proliferation, and lymphatic metastasis in vivo [7–9, 13]. This evidence concerns the gene METTL3 and neoplasm.